Protext Pharma

Protext Pharma is a biotechnology company specializing in the development of pharmaceutical-grade botanical medicines. The company utilizes its proprietary Phyto-V technology, a live plant extraction process designed to capture the full spectrum of bioactive compounds without the use of heat or chemicals. This platform is primarily applied to cannabis and other medicinal plants to create standardized, highly bioavailable formulations. Protext Pharma is currently focused on advancing clinical research for its lead candidates in areas such as viral infections and inflammatory disorders. Through its acquisition of RSAMMD, the company has established a vertically integrated presence in the South African medical cannabis sector. The company aims to bridge the gap between traditional herbal medicine and modern pharmaceutical standards through rigorous clinical validation.